Literature DB >> 19008087

Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators.

Charles N Serhan1.   

Abstract

Using a systems approach to mine spontaneously resolving inflammatory exudates, novel families of lipid- derived mediators were identified in animal systems that control both the duration and magnitude of acute inflammation. These new families were coined with the resolvins and protectins because they possess potent bioactions and novel chemical structures. The mapping of these new resolution circuits has already provided new avenues for appreciating the molecular basis of many inflammatory diseases. This presentation/mini review gives recent advances from our studies on resolvin and protectin biosynthesis and the actions of these novel mediators. These previously unappreciated families of lipid-derived mediators were originally isolated from murine models of acute inflammation captured during the natural spontaneous resolution phase. They are biosynthesized from omega-3 fatty acids and possess potent anti-inflammatory, pro-resolving and anti-fibrotic in vivo actions. These new families of endogenous pro-resolving and anti-inflammatory agonists were also used as biotemplates to design potent mimetics/analogs which were used to confirm each of their structures and specific functions. Moreover, together the identification of these mediators indicate that resolution is an active process at the tissue level in vivo as well as constitute a new genus of anti-inflammatories with a previously unknown pro-resolving mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19008087      PMCID: PMC2629741          DOI: 10.1016/j.plefa.2008.09.012

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  70 in total

1.  Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages.

Authors:  C Godson; S Mitchell; K Harvey; N A Petasis; N Hogg; H R Brady
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

2.  Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution.

Authors:  Eric L Campbell; Nancy A Louis; Sarah E Tomassetti; Geraldine O Canny; Makoto Arita; Charles N Serhan; Sean P Colgan
Journal:  FASEB J       Date:  2007-05-11       Impact factor: 5.191

3.  Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4).

Authors:  Iolanda M Fierro; Jeffery L Kutok; Charles N Serhan
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

4.  Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis.

Authors:  Andrew T Gewirtz; Lauren S Collier-Hyams; Andrew N Young; Torsten Kucharzik; William J Guilford; John F Parkinson; Ifor R Williams; Andrew S Neish; James L Madara
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

5.  Lipid mediator class switching during acute inflammation: signals in resolution.

Authors:  B D Levy; C B Clish; B Schmidt; K Gronert; C N Serhan
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

6.  Prospects for research in inflammatory bowel disease.

Authors:  R S Blumberg; W Strober
Journal:  JAMA       Date:  2001-02-07       Impact factor: 56.272

7.  Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease.

Authors:  M Pouliot; C B Clish; N A Petasis; T E Van Dyke; C N Serhan
Journal:  Biochemistry       Date:  2000-04-25       Impact factor: 3.162

8.  Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia.

Authors:  Geraldine Canny; Ofer Levy; Glenn T Furuta; Sailaja Narravula-Alipati; Richard B Sisson; Charles N Serhan; Sean P Colgan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

9.  Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.

Authors:  Kip M Connor; John Paul SanGiovanni; Chatarina Lofqvist; Christopher M Aderman; Jing Chen; Akiko Higuchi; Song Hong; Elke A Pravda; Sharon Majchrzak; Deborah Carper; Ann Hellstrom; Jing X Kang; Emily Y Chew; Norman Salem; Charles N Serhan; Lois E H Smith
Journal:  Nat Med       Date:  2007-06-24       Impact factor: 53.440

10.  Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.

Authors:  C N Serhan; C B Clish; J Brannon; S P Colgan; N Chiang; K Gronert
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

View more
  31 in total

1.  Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation.

Authors:  Olutayo Odusanwo; Sreedevi Chinthamani; Andrew McCall; Michael E Duffey; Olga J Baker
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-11       Impact factor: 4.249

2.  Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation.

Authors:  Darlene A Dartt; Robin R Hodges; Dayu Li; Marie A Shatos; Kameran Lashkari; Charles N Serhan
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

Review 3.  Lipid mediators in immune regulation and resolution.

Authors:  Derek W Gilroy; David Bishop-Bailey
Journal:  Br J Pharmacol       Date:  2019-03-01       Impact factor: 8.739

4.  2-Polyunsaturated acyl lysophosphatidylethanolamine attenuates inflammatory response in zymosan A-induced peritonitis in mice.

Authors:  Nguyen Dang Hung; Mee Ree Kim; Dai-Eun Sok
Journal:  Lipids       Date:  2011-07-10       Impact factor: 1.880

5.  A defect in the activities of Δ and Δ desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease.

Authors:  Undurti N Das
Journal:  World J Diabetes       Date:  2011-11-15

6.  Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family.

Authors:  Weimin Kong; Jui-Hung Yen; Evros Vassiliou; Sabina Adhikary; Miguel G Toscano; Doina Ganea
Journal:  Lipids Health Dis       Date:  2010-02-01       Impact factor: 3.876

Review 7.  A review of anti-inflammatory agents for symptoms of schizophrenia.

Authors:  William R Keller; Lionel M Kum; Heidi J Wehring; Maju Mathew Koola; Robert W Buchanan; Deanna L Kelly
Journal:  J Psychopharmacol       Date:  2012-11-13       Impact factor: 4.153

8.  Controlled formation of mono- and dihydroxy-resolvins from EPA and DHA using soybean 15-lipoxygenase.

Authors:  Eleanor P Dobson; Colin J Barrow; Jaroslav A Kralovec; Jacqui L Adcock
Journal:  J Lipid Res       Date:  2013-03-07       Impact factor: 5.922

9.  Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.

Authors:  Jayashree A Chandrasekharan; Xiao M Huang; Alexander C Hwang; Neelam Sharma-Walia
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

Review 10.  Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions.

Authors:  Philip C Calder; Gordon L Jensen; Berthold V Koletzko; Pierre Singer; Geert J A Wanten
Journal:  Intensive Care Med       Date:  2010-01-14       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.